Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Clinical Chemistry|November 9, 2012
GALNT9 gene expression is a prognostic marker in neuroblastoma patientsNora Berois, Charles-Henry Gattolliat, Enrique Barrios, et al.Nucleic Acids Research|June 28, 2008
p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cellsEmilie Horvilleur, Matthieu Bauer, David Goldschneider, et al.The American Journal of Pathology|June 24, 2003
MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 modelEtienne Blanc, David Goldschneider, Eric Ferrandis, et al.Cancer Genetics and Cytogenetics|November 19, 2003
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literatureDaniel Satgé, Sam W Moore, Charles A Stiller, et al.Cancer Medicine|June 17, 2014
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patientsCharles-Henry Gattolliat, Gwénaël Le Teuff, Valérie Combaret, et al.Journal of Cell Science|December 17, 2003
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell lineDavid Goldschneider, Etienne Blanc, Gilda Raguénez, et al.Molecular Cancer Therapeutics|August 31, 2012
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutantMona Samy, Charles-Henry Gattolliat, Frédéric Pendino, et al.Blood|September 20, 2002
Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patientsDominique Valteau-Couanet, Christophe Leboulaire, Kim Maincent, et al.Cancer Research|May 6, 2004
In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterationsAlexandre Santos, Loreley Calvet, Marie-Josee Terrier-Lacombe, et al.Cell Cycle (Georgetown, Tex.)|May 13, 2008
Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutationsLaetitia Faridoni-Laurens, Sophie Tourpin, Samar Alsafadi, et al.Pageof 6